GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Realcan Pharmaceutical Group Co Ltd (SZSE:002589) » Definitions » Other Income (Expense)

Realcan Pharmaceutical Group Co (SZSE:002589) Other Income (Expense) : ¥-1,330 Mil (TTM As of Sep. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Realcan Pharmaceutical Group Co Other Income (Expense)?

Realcan Pharmaceutical Group Co's other income expense for the Realcan Pharmaceutical Group Co's pretax income for the three months ended in Sep. 2023 was ¥-33 Mil. Its other income expense for the trailing twelve months (TTM) ended in Sep. 2023 was ¥-1,330 Mil.

Realcan Pharmaceutical Group Co Other Income (Expense) Historical Data

The historical data trend for Realcan Pharmaceutical Group Co's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Realcan Pharmaceutical Group Co Other Income (Expense) Chart

Realcan Pharmaceutical Group Co Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -181.35 -1,666.04 -117.29 -106.51 -1,448.91

Realcan Pharmaceutical Group Co Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 61.93 -1,466.53 39.73 130.04 -32.87

Realcan Pharmaceutical Group Co Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-1,330 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Realcan Pharmaceutical Group Co  (SZSE:002589) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Realcan Pharmaceutical Group Co (SZSE:002589) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Realcan Pharmaceutical Group Co Ltd (SZSE:002589) » Definitions » Other Income (Expense)
Comparable Companies
SZSE:002551 SHSE:603368 SZSE:000950 SZSE:000028 SHSE:600056 SHSE:600739 MCK COR CAH HSIC SHSE:601607 HKSE:01099 MIL:AMP NZSE:EBO XSWX:GALE TSE:7459 TSE:2784 PDCO TSE:9987 XKRX:008930
Traded in Other Exchanges
N/A
Address
No. 326, Airport Road, Zhifu District, Shandong Province, Yantai, CHN, 264004
Website
http://www.realcan.cn
Realcan Pharmaceutical Group Co Ltd is a Chinese company engaged in direct pharmaceuticals distribution services. The company's main business is divided into the Drug, vaccine, medical device circulation service; Medical industry third-party logistics; Medical information service; Medical logistics service; Chinese medicine plate; Hospital management sector; Medical industry research and development production sector; and Medical industry financial sector.

Realcan Pharmaceutical Group Co (SZSE:002589) Headlines

No Headlines